Your browser doesn't support javascript.
loading
Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
Li, Shaoying; Hu, Jiamei; Li, Guisen; Mai, Huifen; Gao, Yinfei; Liang, Bichan; Wu, Huacong; Guo, Jianling; Duan, Yuan.
Afiliación
  • Li S; Department of Thyroid and Breast Surgery, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518000, Guangdong Province, People's Republic of China. syli2018@jnu.edu.cn.
  • Hu J; Department of Thyroid and Breast Surgery, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518000, Guangdong Province, People's Republic of China.
  • Li G; Department of Thyroid and Breast Surgery, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518000, Guangdong Province, People's Republic of China.
  • Mai H; Department of Thyroid and Breast Surgery, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518000, Guangdong Province, People's Republic of China.
  • Gao Y; Department of Thyroid and Breast Surgery, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518000, Guangdong Province, People's Republic of China.
  • Liang B; Department of Thyroid and Breast Surgery, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518000, Guangdong Province, People's Republic of China.
  • Wu H; Department of Thyroid and Breast Surgery, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518000, Guangdong Province, People's Republic of China.
  • Guo J; Department of Thyroid and Breast Surgery, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518000, Guangdong Province, People's Republic of China.
  • Duan Y; Department of Thyroid and Breast Surgery, Baoan Maternal and Child Health Hospital, Jinan University, Shenzhen, 518000, Guangdong Province, People's Republic of China.
Cell Biol Toxicol ; 39(4): 1359-1375, 2023 08.
Article en En | MEDLINE | ID: mdl-36241925
Application of long non-coding RNAs (lncRNAs) for modulation of breast cancer (BC) has attracted much attention. Here, we probed into the role and underlying mechanism of long intergenic non-coding RNA 01270 (LINC01270) in BC. With the help of bioinformatics tools, we identified laminin subunit alpha 2 (LAMA2) as a BC-related differentially expressed gene to discern the effect of LAMA2 in BC cells. LAMA2 was initially poorly expressed while LINC01270 was highly expressed in BC. BC cells were subsequently treated with sh-LINC01270 or/and sh-LAMA2 for exploration of their regulatory mechanism in BC, which unfolded that LINC01270 inhibition up-regulated LAMA2 and inactivated the MAPK signaling pathway to suppress malignant characteristics of BC cells. Functional assays demonstrated that LINC01270 bound to DNMT1, DNMT3a, and DNMT3b promoted the methylation of CpG islands in LAMA2 promoter and inhibited the LAMA2 expression. Moreover, our data suggested that LAMA2 suppressed MAPK signaling pathway to inhibit BC cell malignant characteristics. The in vitro results were re-produced with the help of the in vivo experimentations. In conclusion, LINC01270 silencing inhibited the methylation of LAMA2 promoter to suppress the activation of MAPK signaling pathway, which subsequently restrained the BC progression. 1, Overexpression of LAMA2 inhibits malignant features of BC cells. 2, LINC01270 promotes LAMA2 promoter methylation by recruiting DNMTs to the LAMA2 promoter region. 3, 5-aza-dc reverses the promotion of LAMA2 promoter methylation by LINC01270. 4, LAMA2 inhibits malignant features of BC cells by suppressing the activation of MAPK signaling pathway.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Cell Biol Toxicol Asunto de la revista: TOXICOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Cell Biol Toxicol Asunto de la revista: TOXICOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Suiza